Clinical Trials Logo

Lymphocytic Leukemia, Chronic clinical trials

View clinical trials related to Lymphocytic Leukemia, Chronic.

Filter by:

NCT ID: NCT00143065 Completed - Clinical trials for Lymphocytic Leukemia, Chronic

Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Start date: August 2005
Phase: Phase 2
Study type: Interventional

This purpose of this study is to assess the toxicity and the rate of complete and overall response using fludarabine, rituximab, and alemtuzumab to treat patients with B-chronic lymphocytic leukemia or small lymphocytic leukemia who have received previous treatment.